Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART versus PRR in hypomineralized molars with early carious lesions
IRCT20250209064689N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2026
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of silver diamine fluoride in carious lesion and molar incisor hypomineralisation (MIH) (2 arms), sponsored by Isfahan University of Medical Sciences. Started May 2026; status: completed.
02
Drugs
silver diamine fluoride
03
Conditions
carious lesionmolar incisor hypomineralisation (MIH)
Beyond the preview
Go deeper on IRCT20250209064689N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250209064689N2.